Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges

Publisher： Bentham Science Publishers

E-ISSN： 1875-5305|24|1|71-77

ISSN： 0929-8665

Source： Protein and Peptide Letters, Vol.24, Iss.1, 2016-12, pp. : 71-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The HIV-1 Capsid Protein as a Drug Target: Recent Advances and Future Prospects

By  

Current Protein and Peptide Science, Vol. 14, Iss. 8, 2013-12 ,pp. : 658-668

Bentham Science Publishers

Access to resources Recommend Favorite

Obesity Associated Modulation of miRNA and Co-Regulated Target Transcripts in Human Adipose Tissue of Non-Diabetic Subjects

By  

MicroRNA, Vol. 4, Iss. 3, 2015-12 ,pp. : 194-204

Bentham Science Publishers

Access to resources Recommend Favorite

microRNAs to Monitor Pain-migraine and Drug Treatment

By  

MicroRNA, Vol. 6, Iss. 3, 2017-12 ,pp. : 152-156

Bentham Science Publishers

Access to resources Recommend Favorite

Status Quo in Antibody-Drug Conjugates - Can Glyco- Enzymes Solve the Current Challenges?

By  

Protein and Peptide Letters, Vol. 24, Iss. 8, 2017-10 ,pp. : 686-695

Bentham Science Publishers

Access to resources Recommend Favorite

Disruption of the V-ATPase Functionality as a Way to Uncouple Bone Formation and Resorption - A Novel Target for Treatment of Osteoporosis

By  

Current Protein and Peptide Science, Vol. 13, Iss. 2, 2012-03 ,pp. : 141-151

Bentham Science Publishers

Access to resources Recommend Favorite